B. Cakir Et Al. , "Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): In silico analysis," EUROPEAN JOURNAL OF PHARMACOLOGY , vol.891, 2021
Cakir, B. Et Al. 2021. Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): In silico analysis. EUROPEAN JOURNAL OF PHARMACOLOGY , vol.891 .
Cakir, B., OKUYAN, B., ŞENER, G., & Tunali-Akbay, T., (2021). Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): In silico analysis. EUROPEAN JOURNAL OF PHARMACOLOGY , vol.891.
Cakir, Bilal Et Al. "Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): In silico analysis," EUROPEAN JOURNAL OF PHARMACOLOGY , vol.891, 2021
Cakir, Bilal Et Al. "Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): In silico analysis." EUROPEAN JOURNAL OF PHARMACOLOGY , vol.891, 2021
Cakir, B. Et Al. (2021) . "Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): In silico analysis." EUROPEAN JOURNAL OF PHARMACOLOGY , vol.891.
@article{article, author={Bilal Cakir Et Al. }, title={Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): In silico analysis}, journal={EUROPEAN JOURNAL OF PHARMACOLOGY}, year=2021}